Medfinder
Back to blog

Updated: March 1, 2026

What Is Hemady? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Large medication capsule with information icon and educational elements

Hemady is a brand-name dexamethasone 20mg tablet FDA-approved for multiple myeloma. This guide covers what Hemady is, how it's used, who takes it, and what to expect in 2026.

If you or a loved one has recently been prescribed Hemady, you may have questions about what it is, why it's being prescribed, and what to expect. Hemady is not a new drug exactly — its active ingredient, dexamethasone, has been used in medicine since 1958. But Hemady is a specific, FDA-approved brand formulation that makes a meaningful difference for multiple myeloma patients. Here's everything you need to know.

What Is Hemady?

Hemady is the brand name for dexamethasone 20 mg tablets, manufactured by Edenbridge Pharmaceuticals, LLC. It is an oral corticosteroid — a type of steroid medication that reduces inflammation and has direct anti-cancer effects in multiple myeloma. The FDA approved Hemady in 2019, making it the only dexamethasone formulation specifically FDA-approved for use in combination with other anti-myeloma drugs to treat adults with multiple myeloma.

The key innovation of Hemady is its 20 mg tablet strength. Before Hemady existed, the highest-strength generic dexamethasone tablets were 4 mg — meaning patients needed to take five to ten tablets per dose to achieve the 20 mg or 40 mg doses used in myeloma treatment. Hemady reduces this to just one or two tablets, cutting pill burden by up to 80%. For patients already taking multiple other cancer medications, reducing pill count is a meaningful quality-of-life improvement.

What Is Hemady Used For?

Hemady's FDA-approved indication is: in combination with other anti-myeloma products for the treatment of adults with multiple myeloma. It is not approved as a stand-alone myeloma treatment — it is always used as part of a combination regimen.

Multiple myeloma is a cancer of plasma cells — the white blood cells in your bone marrow responsible for making antibodies. Dexamethasone has two key roles in myeloma treatment:

  1. Direct anti-myeloma effect: Dexamethasone induces apoptosis (programmed cell death) in myeloma cells through glucocorticoid receptor signaling, slowing cancer cell growth.
  2. Enhancing other drugs: Dexamethasone enhances the clinical response rates of other anti-myeloma agents, making the combination more effective than either drug alone.

Common combination regimens that include Hemady (dexamethasone):

  • VRd: Velcade (bortezomib) + Revlimid (lenalidomide) + dexamethasone — common first-line regimen
  • Rd: Revlimid (lenalidomide) + dexamethasone — used in newly diagnosed and relapsed myeloma
  • DRd: Darzalex (daratumumab) + lenalidomide + dexamethasone
  • KRd: Kyprolis (carfilzomib) + lenalidomide + dexamethasone
  • Pd: Pomalyst (pomalidomide) + dexamethasone

Hemady Dosage: What to Expect

The standard Hemady doses for multiple myeloma are 20 mg or 40 mg, taken orally once daily on specific days determined by your treatment regimen. The most common dosing schedule is 40 mg once weekly.

In practical terms: at 40 mg/week, you take 2 Hemady tablets (each 20 mg) once a week on a specific day your oncologist designates. At 20 mg/week, you take 1 Hemady tablet once a week.

Important dosage notes:

  • Hemady can be taken with or without food
  • Dose reduction is recommended for elderly patients (typically 65+) due to increased toxicity risk
  • The exact dosing schedule depends on the other drugs in your regimen — follow your oncologist's specific instructions
  • Safety and effectiveness in pediatric patients has not been established — Hemady is for adults only

What Are the Main Contraindications?

Hemady should not be used by patients who are:

  • Allergic to dexamethasone or any ingredients in Hemady
  • Have an active systemic fungal infection (corticosteroids can worsen fungal infections)
  • Pregnant women should not take Hemady — it can cause fetal harm. Women of reproductive potential must use effective contraception during treatment and for at least one month after the last dose

Is Hemady a Controlled Substance?

No. Hemady is not a DEA-scheduled controlled substance. It does not have refill restrictions based on controlled substance scheduling. Your oncologist can prescribe it with standard (not controlled substance) prescribing procedures. Insurance prior authorization, not DEA scheduling, is the main administrative hurdle for most patients.

How to Fill Your Hemady Prescription

Hemady is a specialty oncology medication not stocked at most retail pharmacies. Your prescription must be filled through a specialty pharmacy such as CVS Specialty, Walgreens Specialty, Accredo, or a hospital pharmacy affiliated with a cancer center. Your oncologist should route the prescription directly to a specialty pharmacy and submit a prior authorization request to your insurance at the same time.

The Bottom Line

Hemady is a high-dose dexamethasone tablet designed specifically for multiple myeloma patients, reducing the pill burden of standard corticosteroid therapy while delivering the same active drug. It is always used in combination with other anti-myeloma medications as part of a comprehensive treatment plan. To understand more about how Hemady works at a cellular level, read our guide on how Hemady works. And if you need help finding it at a pharmacy near you, medfinder can locate pharmacies that have your prescription in stock.

Frequently Asked Questions

Hemady (dexamethasone) 20 mg tablets are FDA-approved for use in combination with other anti-myeloma products for the treatment of adults with multiple myeloma. It is not approved as a standalone treatment — it is always part of a multi-drug regimen such as VRd (bortezomib, lenalidomide, dexamethasone), Rd (lenalidomide, dexamethasone), or DRd (daratumumab, lenalidomide, dexamethasone).

Hemady and generic dexamethasone contain the same active ingredient — dexamethasone. The key difference is the tablet strength: Hemady comes in 20 mg tablets (allowing 1–2 tablets per dose), while generic dexamethasone is available in lower strengths (typically 4 mg), requiring 5–10 tablets per dose to achieve the same therapeutic amount. Hemady is also the only dexamethasone FDA-approved specifically for multiple myeloma use.

Hemady is taken orally — swallowed as a tablet — with or without food. The most common dose is 40 mg (2 tablets of 20 mg each) taken once weekly on a specific day determined by your treatment regimen. Some patients take 20 mg (1 tablet) weekly. Your oncologist will specify the exact dose and schedule based on the other medications in your myeloma treatment plan.

The FDA approved Hemady in 2019. It was developed by Edenbridge Pharmaceuticals, LLC. While dexamethasone itself has been in use since 1958, Hemady's specific 20 mg tablet formulation for multiple myeloma combination therapy is the first and only FDA-approved dexamethasone product indicated for this specific use.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Hemady also looked for:

Dexamethasone 4mg tablets (generic)Dexamethasone oral solution (Dexamethasone Intensol)PrednisoneCompounded dexamethasone

35,181 have already found their meds with Medfinder.

Start your search today.

35K+
5-star ratingTrusted by 35,181 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?